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Abstract: HLA class-I and class-II allele frequencies and two-locus
haplotypes were examined in 367 unrelated Melanesians living on the islands
of Vanuatu and New Caledonia. Diversity at all HLA class-I and class-II loci
was relatively limited. In class-I loci, three HLA-A allelic groups (HLA-A*24,
HLA-A*34 and HLA-A*11), seven HLA-B alleles or allelic groups (HLA-
B*1506, HLA-B*5602, HLA-B*13, HLA-B*5601, HLA-B*4001, HLA-B*4002
and HLA-B*2704) and four HLA-C alleles or allelic groups (HLA-Cw*04, HLA-
Cw*01, HLA-Cw*0702 and HLA-Cw*15) constituted more than 90% of the
alleles observed. In the class-II loci, four HLA-DRB1 alleles (HLA-DRB1*15,
HLA-DRB1*11, HLA-DRB1*04 and HLA-DRB1*16), three HLA-DRB3-5
alleles (HLA-DRB3*02, HLA-DRB4*01 and HLA-DRB5*01/02) and five HLA-
DQB1 alleles (HLA-DQB1*0301, HLA-DQB1*04, HLA-DQB1*05, HLA-
DQB1*0601 and HLA-DQB1*0602) constituted over 93, 97 and 98% of the
alleles observed, respectively. Homozygosity showed significant departures
from expected levels for neutrality based on allele frequency (i.e. excess
diversity) at the HLA-B, HLA-Cw, HLA-DQB1 and HLA-DRB3/5 loci on some
islands. The locus with the strongest departure from neutrality was HLA-
DQB1, homozygosity being significantly lower than expected on all islands
except New Caledonia. No consistent pattern was demonstrated for any HLA
locus in relation to malaria endemicity.
HLA class-I and class-II loci of the major histocompatibility complex
(MHC) are the most polymorphic loci in the human genome. More
than 600 have been described in various populations. The recent
development of polymerase chain reaction sequence-specific oligo-
nucleotide probe (PCR-SSP) methods for HLA typing has facilitated a
more complete description of the full extent of diversity at these loci.
Early studies of the HLA characteristics of populations of Oceania
were based on serology and consistently showed a restricted range of
alleles (1, 2). With the development of DNA typing, finer resolution
and improved understanding of the allelic variation have led to
detailed descriptions of the class-I and class-II HLA types, par-
ticularly for the New Guinea populations (3–5). Data regarding
both class-I and class-II MHC frequencies of populations of Island
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Melanesia are scarce. Vanuatu, an archipelago of 80 islands, lies
within Island Melanesia stretching over a distance of 850 km,
between the Solomon Islands to the north and New Caledonia to
the south (Fig. 1). The indigenous population is Melanesian, although
the remote ancestry is thought to be from Indo-China. The archipelago
of Vanuatu was first settled between 5000 and 6500 years ago in an
expansion from Near Oceania (Papua New Guinea and the Solomon
Islands). Subsequent back migration from the Pacific has introduced
some admixture of Polynesian populations (6). Although the languages
are closely related to those in Polynesia, the physical characteristics of
the population are closer to those of coastal New Guineans and
Austronesian-speaking groups (7). This dual origin is supported by
the alpha globin (of haemoglobin) gene genetics in the presence of both
the –a3.7III deletion, associated with Austronesian speakers in
Oceania and the –a4.2 deletion found predominantly in north coastal
New Guineans (8, 9). In recent history, the Ni-Vanuatu population
experienced a dramatic depopulation between the 1820s and 1920s
(650,000 down to a nadir of 50,000). Many islands of the archipelago
were entirely depopulated (10). Contactwith Europeans led to epidemics
of influenza,measles, smallpox and dysentery, whichwere probably the
principal causes of the near extinction of the Ni-Vanuatu race (11). The
current population of Vanuatu reflects a regenerated population,
because little recent in-migration from the region has occurred and
consequently 98% are reported to be ethnically Ni-Vanuatu.
Vanuatu is situated at the southeastern extreme of malaria transmis-
sion in the Asia–Pacific region. It is not clear whether malaria was
indigenous from the time of colonization or whether it was introduced
more recently. Malaria-like illnesses have been reported from the times
of European contact (approximately 1600s); however, the first official
survey was by Buxton and Hopkins (in 1927), who observed prevalence
rates of 15% for Plasmodium falciparum and 18% for P. vivax (10).
Subsequent surveys have shown P. falciparum, P. vivax and P. malariae
to be endemic on all islands except Futuna. In general, malaria endemi-
city declines from north to south and with increasing altitude (12).
Malaria has never been endemic in New Caledonia (10).
In this study, we have applied PCR-SSP typing to HLA class-I and
class-II alleles from Melanesian populations on six islands in
Vanuatu and New Caledonia with a view to describing, in more
detail, the diversity of HLA class-I and class-II alleles in the region.
Materials and methods
Study site and population
From the archipelago, five islands were chosen for cross-section
surveys. These islands were chosen to reflect the geographical/
cultural/linguistic diversity of the island chain as well as being popula-
tions historically exposed to a broad range of malaria endemicities. A
Melanesian community in New Caledonia was selected to represent a
population that have not been exposed to malaria in recent history.
Sample collection
Blood samples were collected from unrelated people from Vanuatu
and New Caledonia. Details of age, sex, family relationships and
island of origin were collected on all people. Samples derived from
five islands in Vanuatu: Santo (n¼ 146), Paama (n¼ 47), Tanna
(n¼ 64), Aniwa (n¼ 42) and Futuna (n¼ 41) and one Melanesian
community in New Caledonia. HLA typing was also performed on
samples from a Melanesian community in New Caledonia (n¼ 27).
Sample processing and typing
Following centrifugation, buffy coats were separated from the red
cell pellet and the white cells frozen in freezing mix (fetal calf serum
20%, Terasaki Park Medium 70% and DMSO 10%). DNA was
extracted by using a modified salting-out procedure (13). HLA typing
was performed by using a modification of the phototyping set for
HLA-A, HLA-B, HLA-Cw, HLA-DRB1, HLA-DRB3, 4, 5 and HLA-
DQB1 (14). PCR conditions were as previously described (15). Sub-
typing was performed on all HLA-DQB1*06-positive samples and
HLA-B*15-positive samples by means of modified published allele-
specific SSP sets (16, 17). Sub-typing HLA-A*02, HLA-B*13, HLA-
B*27 and HLA-B*56 groups was performed with the help of unpub-
lished local primer mixes (available on request). Primer mix specificities
were updated by using the SSP Manager program (18), which
updated the primer mixes to include the majority of alleles in
the 1998 Nomenclature Report (19), and were updated to include
alleles described in the HLA alleles release 1.5 from the IGMT
database (www.ebi.ac.uk/imgt/hla/).
Statistical analysis
Allele frequencies and two-locus haplotype frequencies were calcu-
lated with the help of a maximum likelihood method by using a
locally designed computer program OXDELTA (unpublished), which
also reported a measure of linkage disequilibrium, D0, and the sig-
nificance of linkage disequilibrium indicated by a w2 sum. Revised
allele frequencies were calculated on the assumption that genotypes,
including homozygotes, were unambiguous, and these were found to
be very similar to those estimated by maximum likelihood. The allele
frequencies (2n) have been reported in Table 2. The Ewens–
Watterson neutrality test was computed by using ARLEQUIN 2.0 (20).
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Fig. 1. Map of Vanuatu. The archipelago of Vanuatu, formerly the New Hebrides. Santo¼Espiritu Santo (167000E, 16000S), Pamma (168200E, 16500S),
Tanna (169200E, 19500S), Aniwa (169500E, 19200S) and Futuna (170100E, 19500S).
Insert: Map of the Southwest Pacific highlighting Vanuatu and its showing relationship with Oceania and New Caledonia.
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Observed homozygosity (F), based on revised allele frequencies, was
compared against a simulated distribution for F based on partitioning
samples of the same size into the same numbers of alleles. This
algorithm gives expected homozygosities assuming neutrality, random
mating, constant population size and no intralocus recombination.
Ethical approval
Ethical approval for this study was granted by the Scientific Ethical
Research Committee, Department of Health, Port Vila, Vanuatu, and
the Central Oxford Research Ethics Committee, Oxford, UK.
Results
A description of the extent of polymorphism and the allele frequen-
cies of 734 class-I and class-II alleles has been presented in Tables 1
and 2. The alleles reported represent a combination of ‘allele level’ and
allele-group level resulting from the combination of low-resolution typing
and limited sub-typing. Table 1 describes the definition of the allele
groups. Table 2 describes gene frequencies for each island.
HLA diversity: distribution
Class-I: HLA-A alleles
We found limited allelic diversity at the HLA-A locus. Three allelic
groups HLA-A*24, HLA-A*34 and HLA-A*11 accounted for over
90% of the diversity, being present at overall frequencies of 62.5,
21 and 14.2%, respectively. Conversely, HLA-A*02 and HLA-A*31
were found infrequently.
HLA-B alleles
We found a higher level of variation at the HLA-B than at the HLA-A
locus. The most common B alleles, in order of frequency, were HLA-
B*5602 (22%), HLA-B*13 (14.1%), HLA-B*1506 (13.6%), HLA-
B*5601 (12.8%), HLA-B*4001 (11.7%) and HLA-B*4002 (8.7%).
The next most common allele was HLA-B*2704, which occurred at
frequencies between 1.1 and 10%. In general, there was a significant
variation between the islands. On Santo, the most common allele was
HLA-B*1506 (26%), found at a frequency of only 10–13% in the
southern islands of Futuna and Aniwa and 5.5% in New Caledonia.
Conversely, the most frequent HLA-B allele in New Caledonia was
HLA-B*5602 (27.8%), which was found at low frequencies on Santo
(8.9%). A similar latitude trend was seen for HLA-B*4001, being
found at high frequency on Futuna (30.4%) and New Caledonia
(18.5%) but at relatively low frequency on Santo (7.2%). Santo
showed the greatest level of diversity at the B-locus, 15 alleles
Definition of allelic groups
HLA-A*11 HLA-A*11011/012/02/03/04/05/06
HLA-A*24 HLA-A*2402101/02102L/022/031/
032/04/05/07/09N/10/11N/14/15/20/23/25/26
HLA-B*13 HLA-B*1301/02/03
HLA-B*18 HLA-B*1801/02/03/05/06/07/08/10
HLA-B*39 HLA-B*39011/013/03/05/09/12/14/15/18
HLA-B*4002 HLA-B*4002/04/06/11/14/27
HLA-B*44 HLA-B*4402/031/032/04/05/07/13
HLA-B*48
A-B*55
HLA-B*4801/03/04/4012,
HLA-B*5501/02/03/05
HLA-Cw*01 HLA-Cw*0102/03/04
HLA-Cw*03 HLA-Cw*0302/041/042/05/06/08/09
HLA-Cw*04 HLA-Cw*04011/012/03/05/07
HLA-Cw*0701 HLA-Cw*07011/012/06
HLA-Cw*0702 HLA-Cw*0702/13
HLA-Cw*1203 HLA-Cw*1203/06
HLA-Cw*14 HLA-Cw*14021/022/03/04
HLA-Cw*15 HLA-Cw*15021/022/03/04/051/052/06
HLA-DRB1*04 HLA-DRB1*04011–0433
HLA-DRB1*07 HLA-DRB1*07011/03
HLA-DRB1*08 HLA-DRB1*0801/021/022/032/041/042
/043/05/06/07/08/10/11/12/13/15/16/17/18/19
HLA-DRB1*11 HLA-DRB1*11011/012/013/041/042/06/
10/12/15/23/24/25/27/28/29/32/37
HLA-DRB1*12 HLA-DRB1*1201/021/022/032/05/06
HLA-DRB1*1401 HLA-DRB1*1401/07/26/35
HLA-DRB1*1404 HLA-DRB1*0821, 1404/05/08/28
HLA-DRB1*15 HLA-DRB1*15011/012/021/022/023
/03/04/05/06/08/09
HLA-DRB1*16 HLA-DRB1*16011/012/021/022/03/04/05/07
HLA-DRB3*01 HLA-DRB3*01011/012/013/014/03/04/05/06
HLA-DRB3*02 HLA-DRB3*0107, 02021/03/05/07/08/11/12
HLA-DRB4*01 HLA-DRB4*01011/02/03101/032/04/05, 0201N
HLA-DRB5*01/02 HLA-DRB5*01011/012/02/03/04/05/06/07
/08N/09/10N, 0202/03/04
HLA-DQB1*0301 HLA-DQB1*03011/012/04/09/10
HLA-DQB1*0302 HLA-DQB1*0302/07/08
HLA-DQB1*0303 HLA-DQB1*03032/033/06
HLA-DQB1*04 HLA-DQB1*0401/02
HLA-DQB1*05 HLA-DQB1*05011/02/031/032/04
Table 1
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HLA class-I and class-II allele frequencies
Island Santo Paama Tanna Aniwa Futuna New Caledonia
2na 292 94 128 84 82 54
HLA-A*01 0.0185
HLA-A*0201 0.0137 0.0078 0.0119 0.0244 0.0185
HLA-A*0206 0.0068 0.0213 0.0234 0.0595 0.0185
HLA-A*03 0.0185
HLA-A*11 0.1918 0.0426 0.1563 0.0238 0.1098 0.1481
HLA-A*24 0.5822 0.6702 0.5781 0.6310 0.6951 0.5926
HLA-A*3101 0.0034 0.0532 0.0156 0.0185
HLA-A*3401 0.2021 0.2128 0.2188 0.2738 0.1707 0.1667
HLA-B*08 0.0185
HLA-B*13 0.1233 0.1915 0.1797 0.2500 0.0488 0.0556
HLA-B*1501 0.0034 0.0106
HLA-B*1506 0.2603 0.0957 0.1484 0.1071 0.1463 0.0556
HLA-B*1521 0.0205 0.0213 0.0234 0.0238
HLA-B*18 0.0582 0.0469 0.0357
HLA-B*2704 0.1062 0.0106 0.0781 0.0119 0.0926
HLA-B*3505 0.0034
HLA-B*39 0.0479 0.0213 0.0469 0.0119 0.0122 0.0185
HLA-B*4001 0.0719 0.0638 0.0547 0.0238 0.3049 0.1852
HLA-B*4002 0.0925 0.0745 0.0781 0.0595 0.2195
HLA-B*4010 0.0103 0.0319 0.0078 0.0238 0.0488
HLA-B*44 0.0122 0.0185
HLA-B*48 0.0391 0.0238 0.0370
HLA-B*55 0.0034 0.0234 0.0185
HLA-B*5601 0.1062 0.1809 0.1484 0.0952 0.0122 0.2222
HLA-B*5602 0.0890 0.2979 0.1250 0.3333 0.1951 0.2778
HLA-B*new 0.0034
HLA-Cw*01 0.0685 0.2447 0.1172 0.3214 0.1098 0.4815
HLA-Cw*0202 0.0034
HLA-Cw*0303 0.0411 0.0106 0.1641 0.0714 0.0610 0.0741
HLA-Cw*0304 0.0274 0.0532 0.0703 0.0119 0.1098 0.0556
HLA-Cw*04 0.4486 0.3085 0.2578 0.3929 0.3780 0.1667
HLA-Cw*0501 0.0122 0.0185
HLA-Cw*0701 0.0582 0.0469 0.0238 0.0185
HLA-Cw*0702 0.1301 0.2447 0.1406 0.0714 0.1098 0.0370
HLA-Cw*0801 0.0391 0.0238 0.0370
HLA-Cw*1202 0.1027 0.0106 0.0859 0.0119 0.0122 0.0926
HLA-Cw*1203 0.0377 0.0426 0.0156 0.0185
HLA-Cw*14 0.0078
HLA-Cw*15 0.0822 0.0851 0.0547 0.0714 0.2073
HLA-DRB1*03 0.0185
HLA-DRB1*04 0.1644 0.1277 0.1328 0.2024 0.2561 0.1296
Table 2
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(including one novel HLA-B allele in a person) being represented.
New Caledonia showed the least diversity with only 11 alleles.
Cw alleles
Only four HLA-C allelic groups were represented frequently: HLA-
Cw*04 (32.5%), HLA-Cw*01 (22.4%), HLA-Cw*0702 (12.2%) and
HLA-Cw*15 (8.3%). Nevertheless, 8–10 C-locus alleles were found in
each island population. Overall, there was wide variation in Cw-allele
frequencies across the island chain with no discernible latitude trends.
Class-II: HLA-DR and HLA-DQ alleles
Three HLA-DRB1 alleles were predominant in all islands: HLA-
DRB1*15 (32%), HLA-DRB1*11 (24%) and HLA-DRB1*04 (17%).
There was some variation in allele frequency between the islands for
these alleles. HLA-DRB1*15 varied between 17% on Aniwa and 44%
on Santo; HLA-DRB1*11 between 12% on Futuna and 36% on
Paama; HLA-DRB1*04 between 11% on Paama and New Caledonia
and 30% on Futuna. HLA-DQB1*0301 (25%) and HLA-DQB1*0601
(25%) were the major HLA-DQB1 alleles on all islands with the
exception of Aniwa, where there was a decrease in HLA-
DQB1*0601 (13%) in favour of an increase in HLA-DQB1*05 (35%).
Homozygosity
The Ewens–Watterson homozygosity statistic was calculated for
each locus. The results have been presented in Table 3. Significant
departures of the observed homozygosity (in the direction of excess
diversity) from the expected values were found for HLA-B, HLA-Cw,
HLA-DQB1 and HLA-DRB3/5. We found no evidence for a departure
from selective neutrality at the HLA-A locus. Diversity was signifi-
cantly greater than expected (i.e. lower homozygosity) for HLA-B on
Santo and Tanna and in the HLA-C locus on Tanna. Departures from
Continued
Island Santo Paama Tanna Aniwa Futuna New Caledonia
2na 292 94 128 84 82 54
HLA-DRB1*0701 0.0119
HLA-DRB1*08 0.0103 0.0319 0.1094 0.0238 0.1707 0.0741
HLA-DRB1*0901 0.0068 0.0078 0.0119 0.0185
HLA-DRB1*10 0.0034
HLA-DRB1*1101 0.2295 0.3936 0.2578 0.1310 0.1220 0.3889
HLA-DRB1*12 0.0068 0.0156 0.0595 0.0366
HLA-DRB1*1401 0.0308 0.0957 0.1094 0.1786 0.0122 0.1111
HLA-DRB1*1404 0.0103 0.0106 0.0781 0.0476 0.1220 0.0185
HLA-DRB1*15 0.4315 0.2979 0.2891 0.1786 0.2805 0.2407
HLA-DRB1*16 0.1062 0.0426 0.1548
HLA-DRB3*01 0.0240 0.0106 0.0952 0.1795 0.1190 0.1111
HLA-DRB3*02 0.2568 0.4894 0.3730 0.1154 0.2976 0.4259
HLA-DRB4*01 0.1781 0.1277 0.1429 0.2692 0.2262 0.1481
HLA-DRB5*01/02 0.5342 0.3404 0.2937 0.3077 0.3333 0.2407
HLA-DQB1*0201/2 0.0185
HLA-DQB1*0301 0.2397 0.3298 0.2656 0.2024 0.1951 0.3889
HLA-DQB1*0302 0.0068 0.0319 0.0156 0.0476 0.1585 0.1111
HLA-DQB1*0303 0.0068 0.0078 0.0238 0.0185
HLA-DQB1*04 0.1575 0.0957 0.1172 0.1429 0.0732 0.0185
HLA-DQB1*05 0.1541 0.2128 0.1953 0.3810 0.1341 0.1481
HLA-DQB1*0601 0.2671 0.2340 0.3281 0.1190 0.3659 0.1296
HLA-DQB1*0602 0.1678 0.0957 0.0703 0.0833 0.0732 0.1667
aNumber of alleles from people on Santo [152], Paama [47], Tanna [66], Aniwa [46], Fortuna [41] and New Caledonia [27]. Because HLA-DRB3,4 and 5 are not present in every person, the figures
presented in Table 2 for these loci do not add up to 100%. The deficit is indicated in the ‘deleted’ field. People with HLA-DRB1*01, *8 and *10 do not have a HLA-DR3/4/5 gene. By island, this
includes (n): Santo (3), Paama (3), Tanna (14), Aniwa (14), Futuna (2) and New Caledonia (2).
Table 2
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expected were stronger and found across more islands for the class-II
loci. Homozygosity was lower than expected on Tanna, Aniwa and
Futuna for both HLA-DRB1 and HLA-DRB3/5. Homozygosity values
were significantly lower than expected in all islands, except New
Caledonia, for HLA-DQB1. Overall, the Tanna population showed the
most consistent picture of elevated diversity across HLA loci.
Haplotypes
Table 4 shows the delta (d), relative delta (D0), w2 and two-locus
haplotype frequencies (HF) in the 367 samples. Haplotypes were
selected by HF> 1.2% plus D0> 0.5. There were many D0 values
greater than 0.95, particularly between HLA-B and HLA-Cw
(HLA-B*1521-Cw*04, HLA-B*48-Cw*0801, HLA-B*18-Cw*0701,
HLA-B*2704-Cw*1202 and HLA-B*39-Cw*0702). Between the class-
II loci, HLA-DRB1 and HLA-DQB, maximum D0 values of 1 were
observed for HLA-DRB1*04-DQB1*0302, HLA-DRB1*1401-
DQB1*05, HLA-DRB1*15-DQB1*0602 and HLA-DRB1*16-DQB1*05.
Maximum D0 values were also observed among HLA-DRB1*12-
DRB3*01, HLA-DRB1*1404-DRB3*01 and HLA-DRB1*04-DRB4*01.
One typically Caucasoid HLA-A1-B8-DR3-DQ2 haplotype was
observed in a person in the New Caledonian population. The other
haplotype in this person (HLA-A*24-B*5602-DRB1*1401-DQB1*05)
was typical of the New Caledonian population. It is likely that the
Caucasian haplotype was generated as a result of admixture with
Europeans.
Discussion
Overall, diversity at all HLA class-I loci was remarkably limited,
three HLA-A, seven HLA-B and six HLA-C alleles or allelic groups
constituting more than 90% of the diversity. Despite this restriction
in class-I alleles, we found considerable variation in allele frequencies
between islands. Similar results were found at the class-II loci, three
HLA-DRB1, three HLA-DR-B3 and two HLA-DQB1 allelic groups
being the most common. The patterns of diversity observed in the
Ni-Vanuatu population are similar to those observed in published
studies of Eastern Melanesian populations (predominantly from
Papuan mainland) (3, 4). However, the confidence in our findings
would have been strengthened by a complete description of the allele-
level diversity by high-resolution typing.
Studies in Africa suggest that certain HLA types, in particular
HLA-B53, may be associated with protection from malaria (21, 22).
Moreover, malaria selection appears to account for the high frequen-
cies of other human genetic polymorphisms in the Pacific (12, 23).
Comprehensive studies of aþ thalassaemia gene frequencies in the
Observed and expected homozygosity
2n Observed Expected P-value
HLA-A
Santo 292 0.417 0.484 0.398
Paama 94 0.5 0.472 0.651
Tanna 128 0.407 0.437 0.511
Aniwa 84 0.477 0.475 0.589
Futuna 82 0.525 0.55 0.505
New Caledonia 54 0.403 0.29 0.868
HLA-B
Santo 292 0.133 0.227 0.046
Paama 94 0.179 0.244 0.209
Tanna 128 0.114 0.217 0.005
Aniwa 84 0.202 0.216 0.532
Futuna 82 0.206 0.289 0.196
New Caledonia 54 0.178 0.208 0.391
HLA-Cw
Santo 292 0.247 0.333 0.255
Paama 94 0.227 0.322 0.171
Tanna 128 0.146 0.262 0.016
Aniwa 84 0.274 0.285 0.557
Futuna 82 0.226 0.326 0.166
New Caledonia 54 0.281 0.231 0.807
HLA-DRB1
Santo 292 0.278 0.334 0.394
Paama 94 0.272 0.365 0.228
Tanna 128 0.198 0.353 0.034
Aniwa 84 0.152 0.255 0.031
Futuna 82 0.205 0.362 0.035
New Caledonia 54 0.245 0.285 0.405
HLA-DRB3/4/5
Santo 292 0.389 0.630 0.093
Paama 94 0.396 0.569 0.172
Tanna 126 0.307 0.580 0.012
Aniwa 78 0.208 0.557 0.008
Futuna 84 0.290 0.557 0.014
New Caledonia 54 0.326 0.526 0.069
HLA-DQB1
Santo 292 0.206 0.433 0.01
Paama 94 0.228 0.427 0.017
Tanna 128 0.235 0.392 0.074
Aniwa 84 0.23 0.37 0.075
Futuna 82 0.226 0.413 0.021
New Caledonia 54 0.231 0.286 0.317
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Maitland et al : HLA frequencies in Vanuatu and New Caledonia
Tissue Antigens 2004 7
U
N
C
O
R
R
E
C
TE
D
P
R
O
O
F
Two-locus haplotypes for all six islands
HF d D0 w2
HLA-A*11 HLA-B*2704/6 0.035 0.61 225.84 0.0438
HLA-A*24 HLA-B*1506 0.043 0.62 62.45 0.1411
HLA-A*24 HLA-B*39 0.008 0.55 270.68 0.0281
HLA-A*24 HLA-B*4001 0.02 0.55 160.54 0.0717
HLA-A*11 HLA-Cw*1202 0.033 0.56 219.94 0.0420
HLA-A*24 HLA-Cw*0304 0.014 0.68 238.21 0.0423
HLA-A*24 HLA-DRB1*12 0.007 1 317.08 0.0165
HLA-A*24 HLA-DQB1*0602 0.03 0.6 112.93 0.1003
HLA-B*1506 HLA-Cw*04 0.094 0.86 91.61 0.1532
HLA-B*1521 HLA-Cw*04 0.012 1 16.3 0.0179
HLA-B*18 HLA-Cw*0701 0.032 0.96 355.39 0.0333
HLA-B*2704/6 HLA-Cw*1202 0.06 0.98 351.27 0.0648
HLA-B*39 HLA-Cw*0702 0.029 0.95 164.77 0.0331
HLA-B*4002/4/6 HLA-Cw*15 0.067 0.88 309.38 0.0749
HLA-B*4010 HLA-Cw*04 0.01 1 14.78 0.0151
HLA-B*4801 HLA-Cw*0801/3 0.012 1 363.11 0.0123
HLA-B*5602 HLA-Cw*01 0.078 0.62 164.68 0.1032
HLA-B*1506 HLA-DRB1*15 0.058 0.51 33.55 0.1117
HLA-B*2704/6 HLA-DRB1*15 0.039 0.87 34.57 0.0602
HLA-B*4002/4/6 HLA-DRB1*1404 0.018 0.51 274.3 0.0209
HLA-B*5601 HLA-DRB3*02 0.048 0.56 30.46 0.0828
HLA-B*1521 HLA-DRB3*02 0.007 0.54 2.91 0.0121
HLA-B*1506 HLA-DRB5*01/02 0.057 0.53 41.02 0.1186
HLA-B*2704/6 HLA-DRB5*01/02 0.037 0.9 40.54 0.0619
HLA-B*2704/6 HLA-DQB1*0601 0.038 0.78 43.12 0.0552
HLA-Cw*04 HLA-DQB1*0602 0.044 0.56 123.99 0.0859
HLA-Cw*1202 HLA-DRB5*01/02 0.034 0.8 35.31 0.0590
HLA-Cw*1202 HLA-DRB1*15 0.036 0.78 28.83 0.0576
HLA-Cw*1202 HLA-DQB1*0601 0.038 0.75 40.79 0.0548
HLA-Cw*15 HLA-DRB1*1404 0.019 0.56 277.19 0.0225
HLA-DRB1*04 HLA-DQB1*0302 0.035 1 275.64 0.0417
HLA-DRB1*04 HLA-DQB1*04 0.098 0.97 264.16 0.1186
HLA-DRB1*08 HLA-DQB1*0601 0.035 0.91 44.72 0.0481
HLA-DRB1*1101/4/6 HLA-DQB1*0301/4 0.171 0.96 302.46 0.2308
HLA-DRB1*12 HLA-DQB1*0301/4 0.01 0.85 14.37 0.0147
HLA-DRB1*1401 HLA-DQB1*05 0.057 1 132.87 0.0706
HLA-DRB1*1404 HLA-DQB1*05 0.029 0.94 78.16 0.0358
HLA-DRB1*15 HLA-DQB1*0602 0.082 1 172.57 0.1203
HLA-DRB1*15 HLA-DQB1*0601 0.109 0.63 92 0.1897
HLA-DRB1*16 HLA-DQB1*05 0.051 1 121.53 0.0633
HLA-DRB1*1101/4/6 HLA-DRB3*02 0.157 0.93 223.76 0.2265
HLA-DRB1*12 HLA-DRB3*01 0.015 1 234.09 0.0165
HLA-DRB1*1401 HLA-DRB3*02 0.048 0.96 51.45 0.0687
HLA-DRB1*1404 HLA-DRB3*01 0.035 1 284.48 0.0375
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South Pacific have demonstrated that the gene frequencies of aþ
thalassaemia in Melanesian island populations vary with both lati-
tude and altitude (12). Furthermore, the current gene frequencies of
aþ thalassaemia parallel the historic incidence of malaria. Thus, a
cline in the –a/HF is seen both from north to south and with
increasing altitude in Oceania (8, 12). To date, however, the only
published HLA frequency data from malaria-endemic populations
within Oceania derive from population studies within Papua New
Guinea (PNG) (1–3). These studies have shown a similarly limited
diversity of HLA-A and HLA-B types within such populations but
substantial variation between populations (2, 3). The most striking
differences observed in these studies were between Highland and
Coastal populations. It has been suggested that the altitudinal cline of
HLA-A alleles within PNG may have resulted from malaria selection
(2). High frequencies of HLA-A*24 were found in Highland popula-
tions (0.764) where malaria is absent, whereas HLA-A*11 predom-
inated (0.628) in Coastal populations naturally exposed to malaria (2).
However, many genetic differences between Coastal and Highland
populations are otherwise attributed to their various colonization
histories. In the current study, we found no consistent pattern with
either HLA-A*24 or HLA-A*11 in relation to malaria endemicity. In
fact, we found the opposite on Santo, which is meso- to hyperendemic
for malaria: HLA-A*24 was the predominant A-locus allele found
(0.58) followed by HLA-A*34 (0.20). HLA-A*11 represented only
19% of the total A-locus alleles found. These observations suggest
that history rather than malarial selection probably accounts for
distributions of HLA-A alleles.
Studies of HLA diversity often report an excess of diversity,
compared to that expected by using the Ewens–Watterson homo-
zygosity test (20), which may indicate the presence of balancing
selection. Balancing selection on HLA reflects multiple pathogenic
challenges to the immune system, which elevates the frequencies of
various alleles at various time periods. Although we found depart-
ures from expected homozygosity, in particular for the class-II loci,
these results varied between islands. Although we have found some
evidence for balancing selection, there are insufficient data from
other malarious areas in the Southwest Pacific to examine whether
malaria selection has been an important determinant in the current
allele frequencies. Our study suggests that substantial genetic drift
associated with population bottlenecks in the colonization of these
islands has contributed to the observed diversity patterns, but
further investigation is warranted.
HLA-DRB1*04 HLA-DRB4*01 0.14 1 343.49 0.1697
HLA-DRB1*15 HLA-DRB5*01/02 0.201 1 281.13 0.3194
HLA-DRB1*16 HLA-DRB5*01/02 0.040 1 46.83 0.0633
HLA-DRB3*01 HLA-DQB1*05 0.031 0.56 63.81 0.0438
HLA-DRB3*02 HLA-DQB1*0301/4 0.147 0.82 187.66 0.2211
HLA-DRB4*01 HLA-DQB1*0302 0.034 1 274.27 0.0417
HLA-DRB4*01 HLA-DQB1*04 0.097 0.97 254.37 0.1186
HLA-DRB5*01/02 HLA-DQB1*0602 0.076 1 157.2 0.1203
HLA-DRB5*01/02 HLA-DQB1*0601 0.093 0.59 60.6 0.1865
Table 4
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